The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular characteristics of advanced colorectal cancer and multi-hit PIK3CA mutations.
 
Michael Cecchini
Stock and Other Ownership Interests - Parthenon Therapeutics
Honoraria - Aptitude Health; DAVA Pharmaceuticals; GRAIL; Macrogenics
 
Ethan Sokol
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Submitted patent for HRD calling methodology (Inst)
 
Neil Vasan
Leadership - Heligenics
Stock and Other Ownership Interests - Heligenics
Honoraria - General Dynamics Information Technology (GDIT); MJH Healthcare Holdings, LLC
Consulting or Advisory Role - Guidepoint Global; Novartis
Patents, Royalties, Other Intellectual Property - Vasan N, Baselga J. U.S. Patent Number WO2020041684A1: “Biomarkers for Determining Responsiveness of a Cancer to PI3K Inhibitors,” Patent granted February 27, 2020.
Travel, Accommodations, Expenses - Novartis
 
Dean C. Pavlick
Employment - Foundation Medicine
Stock and Other Ownership Interests - Roche
 
Richard S.P. Huang
Employment - Roche/Foundation Medicine
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Patent on IHC; provisional patent on biomarkers and biomarker methodology.
 
Maureen Pelletier
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Travel, Accommodations, Expenses - Foundation Medicine
 
Mia Alyce Levy
Employment - Foundation Medicine; SeqTech Diagnostics (I)
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Royalties from GenomOncology for licensing of MyCancerGenome content
 
Lajos Pusztai
Honoraria - Athenex; bioTheranostics; natera; OncoCyte
Consulting or Advisory Role - Almac Diagnostics; AstraZeneca; Bristol Myers Squibb; Clovis Oncology; Eisai; H3 Biomedicine; Immunomedics; Merck; Novartis; Pfizer; Roche/Genentech; Seagen; Syndax
Research Funding - AstraZeneca (Inst); Bristol Myers Squibb (Inst); Genentech (Inst); Merck (Inst); Pfizer (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Foundation Medicine; NanoString Technologies
 
Jill Lacy
Consulting or Advisory Role - Aptitude Health; AstraZeneca; Bionest partners; Celgene; Deciphera; Guidepoint Global; Ipsen; KeyQuest Health; KeyQuest Health; Merck; Navigant Consulting; Novartis; Sirtex Medical; Techspert.io
Travel, Accommodations, Expenses - Lilly
 
Joseph Paul Eder
Stock and Other Ownership Interests - Parthenon Therapeutics
Honoraria - Roche Molecular Diagnostics
Consulting or Advisory Role - Atrin Pharmaceuticals; Roche/Genentech
 
Janie Yue Zhang
Other Relationship - Amgen
 
Jeffrey S. Ross
Employment - Foundation Medicine
Leadership - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Celsius Therapeutics; Tango Therapeutics
Research Funding - Foundation Medicine